ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

Clinton Seeks Cut In NIH Increase

May 27, 1994

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

BMS Settles Charges Of Obstructing Generics

March 14, 2003

Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita

January 27, 1989

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977